comparemela.com
Home
Live Updates
Hypertrophic Cardiomyopathy Center At Lahey Medical - Breaking News
Pages:
Latest Breaking News On - Hypertrophic cardiomyopathy center at lahey medical - Page 1 : comparemela.com
Novel Drug Shows a Signal to Improve nHCM
In the phase 2 IMPROVE-HCM trial, cardiac mitotrope ninerafaxstat was safe, with a signal of improved cardiac function in moderate nonobstructive hypertrophic cardiomyopathy.
Massachusetts
United-states
University-of-pennsylvania
Pennsylvania
Burlington
Philadelphia
Martins-maron
Himabindu-vidula
Journal-of-the-american-college-cardiology
Hypertrophic-cardiomyopathy-center-at-lahey-medical
American-college-of-cardiology
American-college
vimarsana © 2020. All Rights Reserved.